Cross-Bridge versus Thin Filament Contributions to the Level and Rate of Force Development in Cardiac Muscle-Reference-Cited by-同舟云学术

Cross-Bridge versus Thin Filament Contributions to the Level and Rate of Force Development in Cardiac Muscle

Published:2004-09 Issue:3 Volume:87 Page:1815-1824
ISSN:0006-3495
Container-title:Biophysical Journal
language:en
Short-container-title:Biophysical Journal

Author:

Regnier M.,Martin H.,Barsotti R.J.,Rivera A.J.,Martyn D.A.,Clemmens E.

Publisher

Elsevier BV

Subject

Biophysics

Reference39 articles.

1. Cardiac length dependence of force and force redevelopment kinetics with altered cross-bridge cycling;Adhikari;Biophys. J.,2004

2. The cross-bridge cycle in muscle. Mechanical, biochemical, and structural studies on single skinned rabbit psoas fibers to characterize cross-bridge kinetics in muscle for correlation with the actomyosin-ATPase in solution;Brenner;Bas. Res. Cardiol.,1986

3. Effect of Ca2+ on cross-bridge turnover kinetics in skinned single rabbit psoas fibers: implications for regulation of muscle contraction;Brenner;Proc. Natl. Acad. Sci. USA.,1988

4. Isometric force redevelopment of skinned muscle fibers from rabbit with and without Ca2+;Chase;Biophys. J.,1994

5. Effects of inorganic phosphate analogues on stiffness and unloaded shortening of skinned muscle fibres from rabbit;Chase;J. Physiol. (Lond.),1993

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiscale modeling shows how 2’-deoxy-ATP rescues ventricular function in heart failure;Proceedings of the National Academy of Sciences;2024-08-22

2. Dilated Cardiomyopathy in Children;Pediatric Cardiology;2024

3. Cooperative mechanisms underlie differences in myocardial contractile dynamics between large and small mammals;Journal of General Physiology;2023-09-19

4. Multiscale computational modeling of the effects of 2’-deoxy-ATP on cardiac muscle calcium handling;Journal of Applied Physics;2023-08-16

5. Computational Modeling on Drugs Effects for Left Ventricle in Cardiomyopathy Disease;Pharmaceutics;2023-02-28